Skip to main content
Produkt des MonatsProdukt des MonatsBestsellerBestseller Cart

Tranexamic Acid in Cosmetics: A Dark Spot Ingredient Between Medicine and Trend

Tranexamic Acid in Cosmetics: A Dark Spot Ingredient Between Medicine and Trend

Note: image partly or fully created with AI.

The short answer

Tranexamic acid originally comes from medicine, where it is used to stop bleeding. In cosmetics, it has been used topically against dark spots and melasma for several years. Studies on 2–5% concentrations show a moderate but real brightening effect – comparable to hydroquinone, but gentler. Without consistent sun protection, however, the effect remains limited.

What is tranexamic acid – and why is it known from medicine?

Tranexamic acid (INCI: Tranexamic Acid, TXA for short) is a synthetic derivative of the amino acid lysine. Since the 1960s, it has been used as a prescription medicine under names such as Cyklokapron to stop bleeding – for example in heavy menstrual bleeding, surgery or hereditary angioedema. It works by inhibiting fibrinolysis, the body's own breakdown of blood clots.

Around ten to fifteen years ago, dermatologists discovered a side effect more or less by chance: patients taking TXA orally for bleeding reported lighter dark spots. This first led to the medical off-label use (low-dose orally or injected intradermally) against melasma – and, building on this, to cosmetic use in serums and creams at much lower, topical concentrations.

How does tranexamic acid work against dark spots?

Unlike vitamin C or niacinamide, tranexamic acid does not directly inhibit the enzyme tyrosinase, which is central to melanin production. Instead, it acts one step earlier: in the skin, the enzyme plasmin activates a cascade of messengers (including arachidonic acid and prostaglandins), which in turn stimulate melanocytes to produce pigment – amplified by UV light and by subtle vascular changes in the skin. Tranexamic acid blocks this plasmin activity, interrupting the cascade at its root.

Because melasma often has a vascular component – that is, it is accompanied by visible, dilated vessels – tranexamic acid is considered particularly well suited here, as well as for post-inflammatory hyperpigmentation (PIH) after acne or injuries.

What does the research show, critically assessed?

From a regulatory point of view, tranexamic acid is unproblematic under the EU Cosmetics Regulation: the substance is neither on the list of prohibited substances (Annex II) nor on the list of restricted substances (Annex III), and there is no officially prescribed maximum concentration for cosmetic products. In practice, 2–5% is common in serums.

There are now several smaller randomised studies on efficacy: in one frequently cited study, around 75% of participants reported a clear improvement after twelve weeks of daily use; in another study, combined with consistent broad-spectrum sun protection, the figure was as high as around 96%. Compared with hydroquinone, the previous gold standard, topical tranexamic acid showed similar to slightly weaker brightening effects, but with considerably less irritation.

What remains critical: most studies are small (often fewer than 50 participants), short (8–12 weeks) and sometimes funded by or close to manufacturers. Independent long-term data over twelve months or more is still largely lacking. In addition, the effect of oral or injected medical use – for which the most robust evidence exists, though with warnings about thrombosis risks in certain risk groups – cannot be transferred one-to-one to a topical cosmetic serum. When you buy a tube of cream, you don't get the same evidence base as a prescribed tablet. And: melasma is notoriously stubborn and prone to relapse – no ingredient, including tranexamic acid, ‘cures’ it permanently without accompanying UV protection.

In practice: building a routine focused on pigmentation

Sun protection is the real foundation

Whatever brightening ingredient is used: UV light is the strongest trigger for new dark spots and melasma flare-ups. Without daily, consistent sun protection, even the best formulation fizzles out. The mineral The Sun Kiss SPF 30 is suitable as a daily basis to make the effect of brightening skincare possible in the first place.

Add antioxidant cell protection

Oxidative stress encourages both the development and the recurrence of dark spots. The Hydrating Serum with Alteromonas ferment extract supports cellular defence and combines well with serums that specifically target pigmentation.

Keep the barrier stable to avoid new spots

Irritated, damaged skin is more prone to post-inflammatory hyperpigmentation. An intact skin barrier is therefore itself part of pigmentation prevention. The Day Cream with plant lipids and sea buckthorn supports exactly that, without weighing the skin down.

Frequently asked questions about tranexamic acid

Is the tranexamic acid in cosmetic products the same molecule as the medicine?

Chemically yes, it is the same active ingredient. However, concentration and route of application differ greatly: cosmetic products typically contain 2–5% for external use, while the medicine is taken orally or injected at medical doses. The warnings about thrombosis risks that apply to the tablet cannot be directly transferred to topical cosmetic use.

How quickly does topical tranexamic acid work on dark spots?

In studies, the first visible effects usually appear after eight to twelve weeks of consistent daily use – and only in combination with reliable sun protection.

Can tranexamic acid be combined with vitamin C or niacinamide?

In principle, yes. Since the ingredients act at different points of pigment formation, they tend to complement rather than hinder each other. As with any active ingredient, a gradual introduction is recommended to test how well your skin tolerates it.

Conclusion

Tranexamic acid is not a miracle cure, but it isn't just a marketing buzzword either: the research on topical 2–5% formulations shows real, moderate brightening effects on dark spots and melasma, with better tolerability than hydroquinone. However, independent long-term data is still lacking, and the decisive factor is the same in every study: consistent sun protection. If you rely on tranexamic acid for stubborn dark spots, you should see it as one building block alongside daily SPF and a stable skin barrier – for example with Cosmenia's The Sun Kiss SPF 30 and The Day Cream as the basis of a pigmentation-conscious routine.

Want to see more from COSMENIA in your Google search results? Add us as a preferred source.

Comments

Be the first to comment.